将最新的 CIRM 新闻、即将召开的会议的信息以及资金机会发送到您的收件箱。

Through its strategic funding of clinical trials, CIRM helps advance innovative stem cell and gene therapy discoveries toward future treatments for patients. CIRM funds clinical trials across a broad ...

The maximum total funding for a DISC4 Award is $13 million per award. The maximum award duration is four years. Applicant Core Teams must be multi-institutional and include at least five California ...

Objetivo de la investigación Células CAR-iNKT (AlloMCAR-iNKT) dirigidas a mesotelina alogénica diseñada por HSC Impacto en el tratamiento del cáncer de ovario Principales actividades propuestas Hito 1 ...

La misión del Instituto de Medicina Regenerativa de California (CIRM) es acelerar los tratamientos con células madre para pacientes con necesidades médicas no cubiertas. Con nuestro Programas de etapa ...

With a single administration to an individual, lentiviral vectors that selectively transduce B cells in vivo and express highly potent anti-HIV-1 proteins to suppress HIV-1 replication throughout life ...

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

The therapeutic candidate we aim to discover under this award is clomipramine, an antidepressant that might help reduce a harmful protein in the nerve cells of patients with CMT1A disease. The ...

South San Francisco, CA, March 27, 2025 — The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, approved new and ...

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

Our candidate product PSCA-CAR_s15 uiNK is derived from transduction of iPSCs selected from the most ideal source and episomally reprogrammed from mature NK cells or CD34+ cells. Our goal is to ...